Food and Drug Administration weighed in on the matter earlier this summer, warning that it has received "adverse event reports" after patients used compounded semaglutide the active ingredient in Ozempic and Wegovy
Because research-market material is sold outside any approved supply chain, its identity and purity are unverified: published trial data describe a characterized study drug, not the contents of an arbitrary vial, so identity confirmation (for example by mass spectrometry and HPLC) and a batch certificate of analysis are the minimum a rigorous research setting should require
One correction worth making explicitly: the Suicidal Behavior and Ideation subsection was removed from the Wegovy label in the 01/2026 revision
Strong reminder that medication is only one part of the picture
164,267 A pilot, double-blind, placebo-controlled trial in 13 individuals with metabolic syndrome tested, for three months, the combination of 40 mg of the statin drug simvastatin and 100 mg of purified epicatechin
